MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: In vivo effects of MiR-21 inhibitor

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Del Campo, Sara E Martin ^a   Latchana, Nicholas ^a   Levine, Kala M ^b   Grignol, Valerie P ^a   Fairchild, Ene T ^c   Jaime Ramirez, Alena Cristina ^b   Dao, Thao Vi ^d   Karpa, Volodymyr I ^d   Carson, Mary ^a   Ganju, Akaansha ^e   Chan, Anthony N ^d   Carson, William E ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d WRIGHT STATE UNIVERSITY   (United States)

^e NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; MICRORNA 21; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; MICRORNA; MIRN21 MICRORNA, HUMAN; TIMP3 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VIVO STUDY; MELANOMA; MELANOMA CELL LINE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR VOLUME; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SKIN TUMOR; TUMOR CELL LINE;

MUS;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICRORNAS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; SKIN NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84920973815     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115919     Document Type: Article

References (45)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, CA Cancer J Clin. 2013; 63:11-30. doi: 10.3322/caac.21166 PMID: 23335087
2. Horner M, Ries L, Krapcho M, Neyman N, Aminou R, et al. (2009) Surveillance Epidemiology and End Result (SEER) Cancer Statistics Review, 1975-2006. Available from: http://seer.cancer.gov/csr/1975-2006/ - contents. Accessed 10 December 2014.
3. Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, et al. (2012) Melanoma. J Natl Compr Canc Netw. 10:366-400. PMID: 22393197
4. Gaggioli C, Sahai E (2007) Melanoma invasion - current knowledge and future directions. Pigment Cell Res. 20:161-72. doi: 10.1111/j.1600-0749.2007.00378.x PMID: 17516924
5. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, et al. (2003) Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene. 22:2121-34. doi: 10.1038/sj.onc.1206292 PMID: 12687014
6. Hofmann UB, Houben R, Bröcker EB, Becker JC (2005) Role of matrix metalloproteinases in melanoma cell invasion. Biochimie. 87:307-14. doi: 10.1016/j.biochi.2005.01.013 PMID: 15781317
7. Zeng Z, Sun Y, Shu W, Guillem JG (2001) Tissue inhibitor of metalloproteinase-3 is a basement membrane-associated protein that is significantly decreased in human colorectal cancer. Dis Colon Rectum. 44:1290-6. doi: 10.1007/BF02234786 PMID: 11584202
8. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, et al. (2003) Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene. 22:2121-34. doi: 10.1038/sj.onc.1206292 PMID: 12687014
9. Hu S, Liu D, Tufano RP, Carson KA, Rosenbaum E, et al. (2006) Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer. 119:2322-9. doi: 10.1002/ijc.22110 PMID: 16858683
10. Jiang X, Huang X, Li J, Shi Y, Zhou L (2000) Relationship between tissue inhibitors of metalloproteinase and metastasis and prognosis in breast cancer. Zhonghua Wai Ke Za Zhi. 38:291-3, 19. PMID: 12828172
11. Karan D, Lin FC, Bryan M, Ringel J, Moniaux N, et al. (2003) Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. Int J Oncol. 23:1365-71. PMID: 14532978
12. Kettunen E, Anttila S, Seppänen JK, Karjalainen A, Edgren H, et al. (2004) Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet. 149:98-106. doi: 10.1016/S0165-4608(03)00300-5 PMID: 15036884
13. Feng H, Cheung AN, Xue WC, Wang Y, Wang X, et al. (2004) Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma. Gynecol Oncol. 94:375-82. doi: 10.1016/j.ygyno.2004.04.019 PMID: 15297175
14. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-97. doi: 10.1016/S0092-8674(04)00045-5 PMID: 14744438
15. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522-31. doi: 10.1038/nrg1379 PMID: 15211354
16. Dalmay T, Edwards DR (2006) MicroRNAs and the hallmarks of cancer. Oncogene. 25:6170-5. doi: 10.1038/sj.onc.1209911 PMID: 17028596
17. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature. 435:834-8. doi: 10.1038/nature03702 PMID: 15944708
18. Grignol V, Fairchild ET, Zimmerer JM, Lesinski GB, Walker MJ, et al. (2011) miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. Br J Cancer. 105:1023-9. doi: 10.1038/bjc.2011.288 PMID: 21863027
19. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, et al. (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 28:5369-80. doi: 10.1128/MCB.00479-08 PMID: 18591254
20. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, et al. (2009) MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology. 49:1595-601. doi: 10.1002/hep.22838 PMID: 19296468
21. Song B, Wang C, Liu J, Wang X, Lv L, et al. (2010) MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res. 29:29. doi: 10.1186/1756-9966-29-29 PMID: 20346171
22. Satyamoorthy K, DeJesus E, Linnenbach AJ, Kraj B, Kornreich DL, et al. (1997) Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 7 Suppl: 2:S35-42.
23. Lesinski GB, Trefry J, Brasdovich M, Kondadasula SV, Sackey K, et al. (2007) Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells. Clin Cancer Res. 13:5010-9. doi: 10.1158/1078-0432.CCR-06-3092 PMID: 17785551
24. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101-8. doi: 10.1038/nprot.2008.73 PMID: 18546601
25. Srinivasan R, Zabuawala T, Huang H, Zhang J, Gulati P, et al. (2009) Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis. PLoS One. 4:e8283. doi: 10.1371/journal.pone.0008283 PMID: 20011539
26. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 133:647-58. doi: 10.1053/j.gastro.2007.05.022 PMID: 17681183
27. Zhu S, Wu H, Wu F, Nie D, Sheng S, et al. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18:350-9. doi: 10.1038/cr.2008.24 PMID: 18270520
28. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 27:2128-36. doi: 10.1038/sj.onc.1210856 PMID: 17968323
29. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 283:1026-33. doi: 10.1074/jbc.M707224200 PMID: 17991735
30. Zhang Z, Qin Y, Brewer G, Jing Q (2012) MicroRNA degradation and turnover: Regulating the Regulators. WIREs RNA 3:593-600. doi: 10.1002/wrna.1114 PMID: 22461385
31. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR (1994) Tissue inhibitor of metalloproteinases- 3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem. 269:9352-60. PMID: 8132674
32. Yu WH, Yu S, Meng Q, Brew K, Woessner JF (2000)TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem. 275:31226-32. doi: 10.1074/jbc.M000907200 PMID: 10900194
33. Cruz-Munoz W, Sanchez OH, Di Grappa M, English JL, Hill RP, et al. (2006) Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3-/- mice. Oncogene. 25:6489-96. doi: 10.1038/sj.onc.1209663 PMID: 16702949
34. Ahonen M, Baker AH, Kahari VM (1998) Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 58:2310-5. PMID: 9622064
35. Jiang X, Huang X, Li J, Shi Y, Zhou L (2000) Relationship between tissue inhibitors of metalloproteinase and metastasis and prognosis in breast cancer. Zhonghua Wai Ke Za Zhi. 38:291-3, 19. PMID: 12828172
36. van der Velden PA, Zuidervaart W, Hurks MH, Pavey S, Ksander BR, et al. (2003) Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer. 106:472-9. doi: 10.1002/ijc.11262 PMID: 12845640
37. Liu S, Ren S, Howell P, Fodstad O, Riker AI (2008) Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res. 21:545-58. doi: 10.1111/j.1755-148X.2008.00484.x PMID: 18627528
38. Nareyeck G, Zeschnigk M, von der Haar D, Schilling H, Bornfeld N, et al. (2005) Differential expression of tissue inhibitor of matrix metalloproteinases 3 in uveal melanoma. Ophthalmic Res. 37:23-8. doi: 10.1159/000082940 PMID: 15637418
39. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 103:2257-61. doi: 10.1073/pnas.0510565103 PMID: 16461460
40. Zhang Z, Li Z, Gao C, Chen P, Chen J, et al. (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest. 88:1358-66. doi: 10.1038/labinvest.2008.94 PMID: 18794849
41. Li T, Li D, Sha J, Sun P, Huang Y (2009) MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun. 383:280-5. doi: 10.1016/j.bbrc.2009.03.077 PMID: 19302977
42. Storz P, Doppler H, Copland JA, Simpson KJ, Toker A (2009) FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases. Mol Cell Biol. 29: 4906-4917. doi: 10.1128/MCB.00077-09 PMID: 19564415
43. Das AM, Seynhaeve ALB, Rens JAP, Vermeulen CE, Koning GA, et al. (2014) Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration. Angiogenesis 17:163-177. doi: 10.1007/s10456-013-9385-2 PMID: 24221409
44. Wang N, Zhang C, He J, Duan X, Wang Y, et al. (2013) miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma. Dig Dis Sci. 58:1863-1870. doi: 10.1007/s10620-013-2612-2 PMID: 23504349
45. Zhang A, Liu Y, Shen Y, Xu Y, Li X (2011) miR-21 Modulates Cell Apoptosis by Targeting Multiple Genes in Renal Cell Carcinoma. Urology 78: 474.e13-474.e19. doi: 10.1016/j.urology.2011.03.030